Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
16.9 USD | -1.20% | +0.15% | -46.45% |
06:25pm | UBS Adjusts ACADIA Pharmaceuticals' Price Target to $27 From $33, Keeps Buy Rating | MT |
04-23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
Quotes 5-day view
Delayed Quote Nasdaq24/04/2024 | 25/04/2024 | 26/04/2024 | 29/04/2024 | 30/04/2024 | |
---|---|---|---|---|---|
Last | 16.59 $ | 16.31 $ | 16.71 $ | 17.1 $ | 16.76 $ |
Volume | 1 296 887 | 1 660 634 | 1 168 199 | 1 887 790 | 619 957 |
Change | -0.90% | -1.69% | +2.45% | +2.33% | -1.20% |
Opening | 16.81 | 16.50 | 16.45 | 16.90 | 16.77 |
High | 16.86 | 16.51 | 16.74 | 17.57 | 17.17 |
Low | 16.55 | 16.16 | 16.27 | 16.86 | 16.5 |
Performance
1 day | -1.32% | ||
1 week | +0.15% | ||
Current month | -9.33% | ||
1 month | -8.19% | ||
3 months | -37.51% | ||
6 months | -24.58% | ||
Current year | -46.45% | ||
1 year | -22.92% | ||
3 years | -18.46% | ||
5 years | -30.29% | ||
10 years | -16.72% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Other Biotechnology & Medical Research
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-1.20% | +0.15% | -46.45% | -22.92% | 2.82B | ||
-1.52% | -2.72% | +0.33% | +22.18% | 42.86B | ||
-0.68% | +2.93% | +11.66% | -16.75% | 42.74B | ||
-2.30% | -3.04% | +44.30% | -7.77% | 41.36B | ||
+2.89% | +5.76% | -6.20% | +17.68% | 27.68B | ||
-2.16% | -2.58% | +5.46% | +52.74% | 25.15B | ||
-1.73% | -0.79% | -24.29% | -28.21% | 18.63B | ||
-2.68% | -3.88% | +27.68% | +89.53% | 12.37B | ||
-1.65% | -4.69% | -3.19% | +20.39% | 11.92B | ||
-1.31% | +0.36% | +7.02% | +1.38% | 11.21B | ||
-1.81% | -0.15% | -17.58% | -19.73% | 10.14B | ||
-0.21% | +0.53% | -5.95% | -8.74% | 9.36B | ||
-1.29% | -1.23% | +23.31% | -16.20% | 6.68B | ||
-0.94% | +18.86% | +7.53% | -35.02% | 6.65B | ||
+0.96% | +3.14% | +30.40% | +56.81% | 6.33B | ||
-1.24% | -1.05% | -18.17% | +16.03% | 6.12B | ||
Average | -0.95% | +3.39% | +2.24% | +7.59% | ||
Weighted average by Cap. | -0.93% | +3.54% | +7.67% | +8.29% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Last transactions
Date | Price | Volume | Daily volume |
---|---|---|---|
20:36:18 | 16.76 | 100 | 458,397 |
20:36:18 | 16.76 | 100 | 458,297 |
20:36:18 | 16.76 | 100 | 458,197 |
20:36:18 | 16.76 | 100 | 458,097 |
20:36:18 | 16.76 | 588 | 457,997 |
20:36:18 | 16.76 | 614 | 457,409 |
20:35:57 | 16.76 | 307 | 456,795 |
20:35:51 | 16.76 | 100 | 456,488 |
20:35:41 | 16.76 | 100 | 456,388 |
20:35:41 | 16.76 | 100 | 456,288 |
Monthly variations
Annual change
2024 | -45.38% | ||
2023 | +96.67% | ||
2022 | -31.79% | ||
2021 | -56.34% | ||
2020 | +24.96% | ||
2019 | +164.56% | ||
2018 | -46.30% | ||
2017 | +4.40% | ||
2016 | -19.10% | ||
2015 | +12.28% | ||
2014 | +27.05% | ||
2013 | +437.42% | ||
2012 | +330.56% | ||
2011 | -10.00% | ||
2010 | -9.09% | ||
2009 | +46.67% | ||
2008 | -91.87% | ||
2007 | +25.94% | ||
2006 | -10.76% | ||
2005 | +45.49% | ||
2004 | +1.04% |
- Stock Market
- Equities
- ACAD Stock
- Quotes ACADIA Pharmaceuticals Inc.